Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Search
No matching results for ''
Tip: Try a valid symbol or a specific company name for relevant results
Mail
Finance Home
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
The New Investors
All Markets Summit
Give Feedback
Australia markets close in 3 hours 19 minutes
ALL ORDS
7,307.70
-118.90
(-1.60%)
ASX 200
7,069.60
-113.10
(-1.57%)
AUD/USD
0.6995
+0.0036
(+0.51%)
OIL
110.34
+0.75
(+0.68%)
GOLD
1,814.40
-1.50
(-0.08%)
BTC-AUD
41,687.52
-1,740.31
(-4.01%)
📩 Sign up now
News that makes you smarter and richer... For free.
Get Fully Briefed with Yahoo Finance, delivered straight to your inbox.
Soleno Therapeutics, Inc. (SLNO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1719
-0.0184
(-9.67%)
At close: 04:00PM EDT
0.1730
+0.00
(+0.64%)
After hours:
07:16PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
18,277
21,453
23,191
16,267
7,178
Selling general and administrative
10,470
10,806
8,758
6,930
6,556
Total operating expenses
28,747
32,259
31,949
23,197
13,734
Operating income or loss
-28,747
-32,259
-31,949
-23,197
-13,734
Interest expense
-
-
-
-
62
Total other income/expenses net
936
1,239
7,297
-7,731
1,955
Income before tax
-27,680
-30,910
-24,639
-30,774
-11,841
Income tax expense
-
-
-
-
0
Income from continuing operations
-27,680
-30,910
-24,639
-30,774
-11,841
Net income
-27,680
-30,910
-24,639
-30,774
-13,335
Net income available to common shareholders
-27,680
-30,910
-24,639
-30,774
-13,335
Basic EPS
-
-
-0.39
-0.90
-0.64
Diluted EPS
-
-
-0.39
-0.90
-0.64
Basic average shares
-
-
62,620
34,142
20,975
Diluted average shares
-
-
62,620
34,142
20,975
EBITDA
-
-30,296
-29,995
-21,239
-11,771
© 2022 Yahoo. All rights reserved.
Data disclaimer
Help
Suggestions
Privacy Dashboard
Privacy (updated)
About our ads
Terms (updated)